Patient and allograft outcomes after kidney transplant for the Indigenous patients in the United States.
BackgroundThe objective is to assess cardiovascular (CV), malignancy, infectious, graft outcomes and tacrolimus levels for the Indigenous patients compared to Whites after kidney transplant (KTx).Methods165 Indigenous and 165 White patients matched for the KTx year at Mayo Clinic Arizona from 2007-2015 were BROWN RICE SPIRALS studied over a median